Pfizer Can't Shake Fraud Suit Over Risky Arthritis Drugs
A New York federal judge refused Thursday to reconsider Pfizer Inc.'s bid to toss a putative class action securities fraud suit claiming it concealed studies showing heart attack risks associated with...To view the full article, register now.
Already a subscriber? Click here to view full article